Financial Performance - The net assets attributable to unitholders for Global X Hang Seng High Dividend Yield ETF were HK$526,436,175, down from HK$564,778,840 as of March 31, 2022, indicating a decline of approximately 6.8%[7]. - The total liabilities for Global X Electric Vehicle & Battery Active ETF were RMB 1,434,625, which is a significant increase from RMB 362,813 as of March 31, 2022[9]. - Dividend income for Global X MSCI China ETF decreased to HK$40,296,893 from HK$6,829,350, representing a decline of approximately 69.5% year-over-year[11]. - The total comprehensive loss for the period for Global X China Biotech ETF was RMB190,728,491, a significant increase from RMB91,843,733 in the prior year, reflecting a rise of approximately 107%[11]. - The operating loss for Global X High Dividend Yield ETF was HK$136,014,199, compared to HK$3,485,394 in the previous year, indicating a significant increase in losses[11]. - The Global X CSI 300 ETF experienced a loss before tax of RMB 2,820,980, which was higher than the loss of RMB 1,237,690 in the previous year[20]. - For the period ended 30 September 2022, the loss after tax and total comprehensive income for the Hang Seng High Dividend Yield ETF was HK$138,207,752, compared to a loss of HK$3,829,163 for the same period in 2021[154]. Asset and Liability Changes - As of September 30, 2022, the total assets for Global X MSCI China ETF amounted to HK$656,059,610, a decrease from HK$565,620,418 as of March 31, 2022[7]. - The total assets for Global X China Cloud Computing ETF were RMB 20,715,509, down from RMB 29,885,058 as of March 31, 2022, indicating a decline of approximately 30.5%[9]. - The total liabilities and equity for Global X Electric Vehicle & Battery Active ETF were USD 1,678,170, reflecting a stable position compared to previous periods[9]. - The total balance at the end of the period for Global X CSI 300 ETF was RMB654,425,135, compared to RMB182,355,594 at the beginning, reflecting an increase of approximately 258%[13]. - The total cash and cash equivalents at the end of the period for the Global X MSCI China ETF were USD 8,651,320, down from USD 10,962,397 at the beginning of the period[16]. - The total cash and cash equivalents for Global X China Biotech ETF at the end of the period was RMB 14,635,005, down from RMB 20,214,904[22]. Management Fees and Expenses - The management fee payable for Global X MSCI China ETF was HK$1,082,551, which is an increase from HK$477,154 as of March 31, 2022[7]. - Management fees for Global X China Cloud Computing ETF were RMB1,685,450, down from RMB2,510,982, showing a decrease of approximately 33%[12]. - The management fee for the Hang Seng High Dividend Yield ETF for the period ended 30 September 2022 was HK$2,038,587, compared to HK$144,013 for the same period in 2021, reflecting a significant increase[121]. - The management fee for the China Biotech ETF for the period ended 30 September 2022 was RMB2,814,521, down from RMB6,457,134 in the previous year[121]. - The total expenses borne by the Manager for the period ended September 30, 2022, amounted to HK$515,097, compared to HK$270,135 for the same period in 2021, reflecting an increase of approximately 90%[130]. Investment Strategy and Holdings - MSCI China ETF aims to closely correspond to the performance of the MSCI China Index by investing substantially all assets in index securities[35]. - The investment strategy focuses on high-growth sectors, including technology and renewable energy, to capitalize on market trends[170]. - The portfolio includes significant investments in the healthcare sector, such as GUANGZHOU BAIYUNSHAN PHAR-A valued at HK$57,369, which is 0.02% of net assets[172]. - The portfolio reflects a balanced approach with investments in both established firms and high-potential growth companies across different industries[189]. - The investment strategy focuses on high-growth sectors, with substantial allocations to renewable energy and technology companies[189]. Unit and Share Information - The number of units in issue for Global X MSCI China ETF decreased from 22,600,000 to 21,600,000, indicating a reduction of about 4.4%[13]. - The total number of units redeemed during the period for Global X China Biotech ETF was 2,100,000, reflecting a decrease in investor interest[13]. - The total number of units in issue at the end of the period for the Global X China Cloud Computing ETF was 9,900,000, down from 9,950,000 at the beginning of the period[15]. - The Hang Seng ESG ETF issued 57,000,000 units, raising HK$212,605,200 in investments and cash balances[108]. - The Metaverse Theme Active ETF issued 300,000 units, raising USD 2,263,306 since its inception on March 18, 2022[109]. Cash Flows and Financing Activities - The net cash flows generated from operating activities amounted to HK$ 137,523,322, a significant increase from HK$ 39,395,986 in the previous period[16]. - Cash received from the issue of units was HK$ 59,912,217, while cash paid on redemptions of units was HK$ 207,457,876, resulting in net cash flows used in financing activities of HK$ 147,545,659[16]. - Net cash flows used in financing activities for Global X China Biotech ETF were RMB 84,307,524, compared to RMB 167,910,563 in the prior period[22]. Market and Investment Performance - The net total returns of the underlying index of the Global X Hang Seng ESG ETF were -20.9%, compared to -17.3% for the Base Index during the same period[167]. - The fair value of holdings in the MSCI China ETF as of September 30, 2022, includes CHINA YANGTZE POWER CO LTD-A valued at HK$808,209, representing 0.24% of net assets[171]. - The total fair value of the listed equities in the portfolio reflects a diverse range of sectors, including technology, finance, and energy[171]. - The portfolio shows a strong presence in the technology sector with investments in companies like BOE Technology Group valued at HK$ 191,800 million, which is 0.06% of net assets[170]. - The total fair value of the holdings in the portfolio is diversified across various sectors, with significant investments in banking and energy sectors[170].
中绿(00904) - 2023 - 中期财报